Matthew Taylor

Q: How accurate are Matthew Taylor's stock ratings?

About 49% of Matthew's ratings were profitable over a one-year hold, with an average return of -1.5% per rating, measured by 13Foresight from historical prices.

Q: How is Matthew ranked?

Matthew Taylor is ranked #2629 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Jefferies

Wall Street Analyst

★★☆☆☆

#2629

on 13Foresight · ranked by our own returns

49%

Success Rate

-1.5%

Average Return

26 of 53 calls profitable · -13.5% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 49% of Matthew Taylor's ratings turned a profit when each position was held for 1 year — averaging -1.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

51 Buy 5 Hold 0 Sell

Matthew's Stock Coverage 39 ratings · 2026-09-30

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
SYK Stryker	Sep 22, 2026	BUY	Strong Buy +29.6% avg upside 37 analysts	$405.00 45.26% Upside	+1.3%	·
BSX Boston Scientific	Sep 11, 2026	BUY	Strong Buy +51.9% avg upside 38 analysts	$60.00 36.72% Upside	+2.6%	·
EW Edwards Lifesciences	Sep 11, 2026	BUY	Strong Buy +14.8% avg upside 34 analysts	$105.00 19.14% Upside	+4.4%	·
BDX Becton Dickinson	Sep 08, 2026	BUY	Buy +8.4% avg upside 25 analysts	$210.00 15.40% Upside	+0.4%	·
ESTA Establishment Labs Holdings	Sep 08, 2026	BUY	Strong Buy +48.7% avg upside 12 analysts	$105.00 64.77% Upside	-13.8%	·
MDT Medtronic	Sep 02, 2026	HOLD	Buy +15.4% avg upside 38 analysts	$95.00 9.13% Upside	-2.1%	·
ABT Abbott Laboratories	Aug 21, 2026	BUY	Strong Buy +16.0% avg upside 36 analysts	$135.00 33.74% Upside	-13.4%	·
GEHC GE Healthcare Technologies Inc	Jul 30, 2026	BUY	Strong Buy +24.5% avg upside 23 analysts	$92.00 38.34% Upside	-5.0%	·
RMD Resmed	Jul 10, 2026	HOLD	Buy +3.7% avg upside 27 analysts	$225.00 0.97% Upside	+9.2%	·
LNTH Lantheus	Mar 18, 2026	BUY	Buy -18.7% avg upside 21 analysts	$110.00 10.54% Upside	+24.4%	·
PODD Insulet	Feb 19, 2026	BUY	Strong Buy +63.7% avg upside 32 analysts	$400.00 201.07% Upside	-47.6%	·
DXCM Dexcom	Feb 13, 2026	BUY	Strong Buy +22.7% avg upside 32 analysts	$112.00 29.32% Upside	+23.7%	·
BAX Baxter International	Feb 12, 2026	HOLD	Buy +42.1% avg upside 23 analysts	$19.00 19.06% Downside	+24.4%	·
GMED Globus Medical	Jan 08, 2026	BUY	Strong Buy +23.1% avg upside 24 analysts	$115.00 51.91% Upside	-20.8%	·
TNDM Tandem Diabetes Care	Nov 07, 2025	BUY	Buy +92.8% avg upside 29 analysts	$48.00 189.77% Upside	-3.3%	·
VREX Varex Imaging	Oct 03, 2025	HOLD	Buy +8.1% avg upside 10 analysts	$12.00 35.02% Downside	+54.7%	·
SI Shoulder Innovations, Inc.	Aug 25, 2025	BUY	Strong Buy +25.3% avg upside 5 analysts	$19.00 0.68% Upside	+48.6%	·
LIVN LivaNova	Aug 07, 2025	BUY	Strong Buy +4.0% avg upside 15 analysts	$80.00 3.89% Upside	+57.1%	·
ZBH Zimmer Biomet Holdings	Aug 07, 2025	HOLD	Buy +26.1% avg upside 38 analysts	$110.00 20.55% Upside	-0.9%	·
SIBN SI-Bone	Aug 05, 2025	BUY	Strong Buy +36.6% avg upside 18 analysts	$28.00 46.16% Upside	+12.8%	·
ALUR Allurion Technologies	Jun 04, 2025	BUY	Strong Buy +8948.3% avg upside 4 analysts	$18.00 1614.30% Upside	-69.2%	·
ISRG Intuitive Surgical	May 02, 2025	HOLD	Strong Buy +16.5% avg upside 36 analysts	—	-13.5%	·
TFX Teleflex	May 01, 2025	HOLD	Buy +48.2% avg upside 20 analysts	$145.00 14.70% Upside	-2.1%	·
AU:TLX Telix Pharmaceuticals	Apr 28, 2025	BUY	Strong Buy +65.7% avg upside 14 analysts	$34.50 113.68% Upside	-44.3%	·
INMD InMode	Apr 14, 2025	BUY	Buy +36.7% avg upside 9 analysts	$15.00 5.52% Upside	-6.2%	·
SENS Senseonics Holdings	Mar 04, 2025	SELL	Buy +49.2% avg upside 13 analysts	$6.00 40.33% Downside	+51.1%	·
IART Integra Lifesciences	Jul 16, 2024	BUY	Buy +162.7% avg upside 21 analysts	$48.00 188.44% Upside	-61.9%	·
CNMD Conmed	Feb 01, 2024	HOLD	Hold +39.6% avg upside 12 analysts	$105.00 124.80% Upside	-13.4%	·
OBIO Orchestra BioMed Holdings	Jan 19, 2024	BUY	Strong Buy +110.5% avg upside 10 analysts	$14.00 130.23% Upside	-39.5%	·
CH:SOON Sonova Holding AG	Oct 28, 2022	HOLD	Hold -10.5% avg upside 18 analysts	$255.00 1.11% Upside	-9.8%	·
PEN Penumbra	Oct 12, 2022	BUY	Buy +3.6% avg upside 23 analysts	$230.00 27.85% Downside	+7.1%	·
UTRS Minerva Surgical	Mar 09, 2022	BUY	Buy +7999900.0% avg upside 4 analysts	$14.00 13999899.94% Upside	·	·
BFLY Butterfly Network	Mar 01, 2022	HOLD	Strong Buy -15.1% avg upside 10 analysts	$5.50 39.50% Downside	-54.2%	·
BKNG Booking Holdings	Feb 07, 2022	BUY	Strong Buy +549.6% avg upside 56 analysts	—	+0.2%	·
NL:PHIA Koninklijke Philips N.V.	Jan 25, 2022	BUY	Buy +39.3% avg upside 21 analysts	$49.00 125.43% Upside	-44.8%	·
DE:SHL Siemens Healthineers AG	Dec 06, 2019	HOLD	Buy +26.9% avg upside 24 analysts	—	-4.6%	·
LFWD Lifeward	Mar 08, 2018	SELL	Strong Buy +5.7% avg upside 8 analysts	$1.00 85.61% Downside	·	·
ANGO AngioDynamics	Jul 19, 2017	HOLD	Strong Buy +14.0% avg upside 9 analysts	$16.00 2.58% Upside	+41.2%	·
EVARF Lombard Medical	May 12, 2016	HOLD	Hold +249999900.0% avg upside 1 analyst	$2.50 249999899.96% Upside	·	·

🔒 34 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Matthew Taylor — Frequently Asked Questions

How accurate are Matthew Taylor's stock ratings?

Based on the calls 13Foresight could measure, about 49% of Matthew's ratings were profitable over a one-year hold, with an average return of -1.5% per rating, or -13.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Matthew ranked on 13Foresight?

Matthew Taylor is currently ranked #2629 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Matthew cover?

Matthew most recently has ratings on SYK, BSX, EW, BDX, ESTA, MDT, ABT, GEHC, RMD, LNTH, PODD, DXCM and 27 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Matthew Taylor

Rating Distribution

Welcome to 13Foresight!